secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2022-04-29T23:59:59+00:00
Accession:  0001193125-22-134322
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Richard J. Wanstall resigns effective May 6, 2022 for other opportunity
---------------------------------------------------------------------------

- Richard J. Wanstall, CFO and principal accounting officer, resigns effective May 6, 2022 to pursue another career opportunity.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Aileron has initiated a search for a new CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312522134322/0001193125-22-134322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312522134322/d266198d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-134322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer